论文部分内容阅读
目的:对应用孟鲁司特与普米克气雾剂联合对患有哮喘疾病的患儿实施治疗的临床效果进行研究。方法:选择在井研县人民医院2012年10月-2014年10月就诊的患有哮喘疾病的患儿88例,随机分为对照组和观察组,平均每组44例。采用普米克气雾剂对对照组患儿实施治疗;采用孟鲁司特与普米克气雾剂联合对观察组患儿实施治疗,比较两组患儿的治疗效果。结果:观察组患儿哮喘症状消失时间、呼吸功能指标水平恢复正常时间、哮喘疾病药物治疗总时间明显短于对照组(P<0.05);观察组患儿的哮喘疾病控制总有效率达到93.1%,而对照组为72.8%(P<0.05);哮喘治疗过程中出现的不良反应明显少于对照组(P<0.05)。结论:应用孟鲁司特与普米克气雾剂联合对患有哮喘疾病的患儿实施治疗的临床效果非常明显。
OBJECTIVE: To study the clinical effects of montelukast and pulmicort aerosol in the treatment of children with asthma. Methods: 88 children with asthma who were treated in Jingyan People’s Hospital from October 2012 to October 2014 were randomly divided into control group and observation group, with an average of 44 in each group. Pulmicort aerosol was used to treat children in the control group. Montelukast and Pulmicort aerosol were used to treat the observation group, and the therapeutic effect was compared between the two groups. Results: The disappearance time of asthma symptoms, the resumption of normal respiratory function index and the total time of treatment for asthma were significantly shorter in the observation group than in the control group (P <0.05). The total effective rate of asthma control in the observation group was 93.1% , While the control group was 72.8% (P <0.05). The adverse reactions in the treatment of asthma were significantly less than those in the control group (P <0.05). CONCLUSIONS: The clinical effect of montelukast and pulmicort aerosol in the treatment of asthmatic children is very evident.